AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2023
Nov 13, 2023
30826_dirs_2023-11-13_55fa2a30-43f4-46ba-9fdb-ab94a3cb66e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2023-11-10
Reporting Person: Gebski Christine (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-10 | Common Stock | S | 3788 | $147.13 | Disposed | 28787 | Direct |
More from REPLIGEN CORP
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 6
Earnings Release
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23